| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |